Alkem Laboratories Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alkem launches Olesoft Trucera, an advanced ceramide-boostingmoisturizing lotion for skin barrier repair.".
ALKEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alkem Laboratories has launched Olesoft Trucera, a new ceramide-boosting moisturizing lotion designed to restore hydration, strengthen the skin barrier, and soothe skin flare-ups. The product contains N-Palmitoyl Serinol, a blend of five ceramides, dual oat-extract actives, and Niacinamide, and will be available on prescription. It is an extension of Alkem's existing Olesoft range, which includes Olesoft Max (the most prescribed moisturizer by dermatologists in India, per SMSRC April 2025 data) and Olesoft Lite (named 'Best Launch of the Year' in face moisturizers by IQVIA in June 2025). The launch supports Alkem's strategy of expanding in high-growth dermatology and chronic therapy segments.
This is a routine product launch in the dermatology segment, reinforcing Alkem's presence in the skincare/moisturizer category, but no revenue or financial guidance is provided. Expect minimal direct impact on the stock price, though it adds to the company's chronic and dermatology portfolio growth story.